Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer
Clinical trial NCT00298896 · COMPLETED
Trial details
- NCT number
- NCT00298896
- Sponsor
- Sunesis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2007-08-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.